Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Relapse (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06563804
What this trial is testing

Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML

Who this might be right for
Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLChronic Myelomonocytic Leukemia (CMML)
Servier Bio-Innovation LLC 13
Early research (Phase 1)Ended earlyNCT00852709
What this trial is testing

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaMyeloproliferative Disorders+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Early research (Phase 1)Active Not RecruitingNCT03560882
What this trial is testing

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

Who this might be right for
Malignant DiseaseSolid TumorAcute Myeloid Leukemia+3 more
Joaquina Baranda 50
Early research (Phase 1)Not Yet RecruitingNCT07441980
What this trial is testing

A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia(AML)
Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Looking for participantsNCT06125652
What this trial is testing

Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Xuzhou Medical University 20
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Early research (Phase 1)Study completedNCT03263936
What this trial is testing

Epigenetic Reprogramming in Relapse/Refractory AML

Who this might be right for
Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 37
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Early research (Phase 1)Study completedNCT03671564
What this trial is testing

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Daiichi Sankyo Co., Ltd. 14
Testing effectiveness (Phase 2)Looking for participantsNCT04838041
What this trial is testing

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia
Medical College of Wisconsin 51
Not applicableNot Yet RecruitingNCT06385808
What this trial is testing

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Who this might be right for
Relapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more
First Affiliated Hospital Xi'an Jiaotong University 37
Early research (Phase 1)Ended earlyNCT03125876
What this trial is testing

A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Sunshine Lake Pharma Co., Ltd. 12
Not applicableWithdrawnNCT03121079
What this trial is testing

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Who this might be right for
Interferon-A-2BRelapsePrevention+1 more
Peking University People's Hospital
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT03600155
What this trial is testing

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Looking for participantsNCT07106749
What this trial is testing

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Ended earlyNCT01550185
What this trial is testing

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT00565058
What this trial is testing

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Aptose Biosciences Inc. 27
Testing effectiveness (Phase 2)Study completedNCT04173585
What this trial is testing

TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib

Who this might be right for
Acute Myeloid Leukemia
University Hospital Heidelberg 50
Testing effectiveness (Phase 2)Study completedNCT03823352
What this trial is testing

Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients

Who this might be right for
Leukemia, Myeloid, Acute
Golden Biotechnology Corporation 12
Next Page